Partial trisomy and tetrasomy of chromosome 21 without dowsyndrome phenotype and short overview of genotype-phenotype correlation. A case report

Biomedical Papers

Volumn 158, Issue 2, 2014, Pages 321-325

  Capkova, Pavlina ^a   Misovicova, Nadezda ^b   Vrbickaa, Dita ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b Martinska Fakultna Nemocnica   (Slovakia)

Author keywords

Down syndrome; Down syndrome critical regio(DSCR); Partial trisomy tetrasomy of chromosome 21

Indexed keywords

CASE REPORT; CHROMOSOME 21; DOWN SYNDROME; GENETICS; GENOTYPE; HUMAN; INFANT; KARYOTYPE; MALE; PHENOTYPE; PRESCHOOL CHILD; TETRASOMY; TRISOMY;

CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; GENOTYPE; HUMANS; INFANT; KARYOTYPE; MALE; PHENOTYPE; TETRASOMY; TRISOMY;

EID: 84903595907     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2013.077     Document Type: Article

References (21)

1. Delacruz FF, Gerald PS. DowSyndrome; Research perspectives. Baltimore: University Park Press;1981.
2. Korenberg JR, Kawashima H, Pulst SM. Molecular definitioof a regioof chromosome 21 that causes features of the Dowsyndrome phenotype. Am J Hum Genet 1990;47:236-46.
3. CheH, Tyrkus M, Woolley PV. Double aneuploidy: partial trisomy 21 and XO/XXX ia family with 12/21 translokation. AnGenet 1978;21:177-80.
4. Rauch A, Pfeiffer RA, TrautmanU, Liehr T, Rott HD, Ulmer R. A study of tesmall supernumerary (marker) chromosomes identified by fluorescence isitu hybridization. CliGenet 1992,42:84-90.
5. Schinzel A. Catalogue of unbalanced chromosomal aberrations iman. 2nd Revised and Expanded EditioNew York: Walter de Gruyter; 2001.
6. Cerretini R, Luccerini V, Stivel M. Tetrasomy 21pter-->q22.11, Molecular, cytogenetics and clinical findings. CliGenet 1999;55:283-6.
7. Daumer-Haas C, Schuffenhauer S, Walter JU, Schiller RD, PorstmanT, Korenberg JR. Tetrasomy 21 pter-->q22.1 and Dowsyndrome: molecular definitioof the region. Am J Med Genet 1994;53:359-65.
8. Hagemeijer A, Smit EME. Partial trisomy 21. Futher evidence that trisomy of band 21q22 is essential for Down's phenotype. Hum Genet 1977;38:15-23.
9. Nadal M, Moreno S, Pritchard M, Preciado MA, Estivill X, Ramos-Arroyo MA. Dowsyndrome: characterisatioof a case with partial trisomy of chromosome 21 owing to a paternal balanced translocatio(15;21) (q26;q22.1) by FISH. J Med Genet 1997;34:50-4.
10. Park JP, Wurster-Hill DH, Andrews PA, Cooley WC, Graham JM, Jr. Free proximal trisomy 21 without the Dowsyndrome. CliGenet 1987;32:342-8.
11. Delabar JM, Theophile D, Rahmani Z. Molecular mapping of twentyfour features of Dowsyndrome ochromosome 21. Eur J Hum Genet 1993;1:114-24.
12. McCormic MK, Schinzel A, PeterseMB, StetteG, Driscoll DJ, Cantu ES, Tranebjaerg L, MikkelseM, Watkins PC, Antonarakis SE. Molecular genetic approach to the characterizatioof the "Dowsyndrome region" of chromosome 21. Genomics 1989;5:325-31.
13. Antonarakis SE, WarreAC, McCormick M, Lewis JG, Hieter PA, Chakravarti A. Molecular and Cytogenetic studies of No- Disjunction. AlaR. Liss, Inc.;1989: 29-43.
14. Korenberg JR, Bradley C, Disteche CM. Dowsyndrome: molecular mapping of the congenital heart disease and duodenal stenosis. Am J Hum Genet 1992;50:294-302.
15. Gutiérrez-Angulo M, Ramos AL, Dávalo N, Sánchez-Corona J, Rivera H. Aextra idic (21)(q22,1) ichild with some features os Down's syndrome. CliGenet 1999;55:203-6.
16. Korbel JO, Tirosh-Wagner T, UrbaAE, CheXN, Kasowski M, Dai L, Grubert F, ErdmaCh, Gao MC, Lange K, Sobel EM, Barlow GM, Aylsworth AS, Carpenter NJ, Clark RD, CoheMY, DoraE, Falik- Zaccai T, LewiSO, Lott IT, McGillivray BC, Moeschler JB, Pettenati MJ, Pueschel SM, Rao KW, Shaffer LG, Shohat M, VanRiper AJ, WarburtoD, WeissmaS, GersteiMB, Snyder M, Korenberg JR. The genetic architecture of Dowsyndrome phenotypes revealed by high-resolutioanalysis of humasegmental trisomies. PNAS 2009;106:12031-6.
17. Korenberg JR, CheXN, Schipper R, SuZ, Gonsky R, Gerwehr S, Carpenter N, Daumer C, DignaP, Disteche C. Dowsyndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA 1994;91:4997-5001.
18. Niikawa N, Deng HX, Abe K, Harada N, Okada T, Tsuchiya H, Akaboshi I, Matsuda I, Fukushima Y, Kaneko Y, Kuwano A, Kajii T. Possible mapping of the gene for transient myeloproliferative syndrome at 21q11.2. Hum Genet 1991,87:561-6.
19. SheJJ, Williams BJ, Zipursky A, Doyle J, ShermaSL, Jacobs PA, Shugar A L, Soukup SW, Hassold TJ. Cytogenetic and molecular studies of Dowsyndrome individuals with leukemia. Am J Hum Genet 1995,56:915-25.
20. Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, Hashimoto R, Tanaka T, Kudo T, Yamagata H, Tabara Y, Miki T, Akatsu H, Kosaka K, Funakoshi E, Nishitomi K, Sakaguchi G, Kato A, Hattori H, Uema T, Takeda M. DYRK1A gene, encoded ichromosome 21 Dowsyndrome critical region, bridges betwee{beta}-amyloid productioand tau phosphorylatioiAlzheimer disease. Hum Mol Genet 2007;16:15-23.
21. Rowe LR, Lee JY, Rector L, Kaminsky EB, BrothmaAR, MartiCL, South ST. U-type exchange is the most frequent mechanism for inverted duplicatiowith terminal deletiorearrangements. J Med Genet 2009;46:694-702.